HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Treatment Guidelines

Cardiology Month in Review: August 2022

August 27, 2022

Our cardiology month in review spotlights the most popular content from the past month. The top content from August 2022 includes new antithrombotic guidance from CHEST, USPSTF recommendation statement on statin use in primary prevention, and coverage of ESC 22, including DELIVER, TIME, and other late-breaking data.

USPSTF Reaffirms Endorsement for Statin Use in Primary Prevention Settings

August 23, 2022

The USPSTF released a new recommendation statement on August 23 outlining the organization's stance on use of statins for primary prevention based on current available evidence, with recommendations made for those 40-75, 75 and older, and based on 10-year CVD risk.

New US Preventive Services Task Force Recommendations on Diet, Activity Counseling to Prevent Cardiovascular Disease

July 26, 2022

On July 26, the US Preventive Services Task Force released an updated recommendation statement outlining the organization's stance on behavioral counseling aimed at improving diet and physical activity in adults without cardiovascular risk factors, which was awarded a level C recommendation and is consistent with their 2017 recommendations on the topic.

Cardiology Month in Review: May 2022

May 28, 2022

Our cardiology month in review spotlights the most popular content from the past month. This month's top articles include news from DELIVER, new guidelines for ICH and PFO, and a juxtaposition of international heart failure guidelines.

Don't Miss a Beat: Interpreting New Heart Failure Guidelines

May 04, 2022

In this episode of Don't Miss a Beat, hosts Drs. Greene and Vaduganathan break down the new ACC/AHA/HFSA heart failure guidelines debuted at ACC.22 and compare the recommendations against those made in the European Society of Cardiology's 2021 heart failure guidelines.

USPSTF Releases Updated Recommendations on Aspirin Use for Primary Prevention of Cardiovascular Disease

April 26, 2022

Published in JAMA on April 26, the latest recommendation statement from the USPSTF gives a grade C recommendation for use of low-dose aspirin for primary prevention of cardiovascular disease in adults aged 40-59 years who have a 10% or greater 10-year cardiovascular disease risk, concluding it could provide a small net benefit in these patients.

AHA Calls Attention to Growing Impact of NAFLD on Cardiovascular Disease Risk

April 14, 2022

The latest scientific statement from the American Heart Association is aimed at improving the awareness of NAFLD and its associated cardiovascular risk among clinicians as well as optimizing diagnosis and early treatment strategies for patients with NAFLD.